Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Diabetes

Date Submitted: May 19, 2025
Date Accepted: Aug 20, 2025

The final, peer-reviewed published version of this preprint can be found here:

Prevalence and Risk Factors of Metabolic Dysfunction–Associated Steatotic Liver Disease in Patients With Type 2 Diabetes Mellitus at a Tertiary Center in Saudi Arabia: Cross-Sectional Questionnaire Study

Elnasieh A, Almesned M, Al Hazmi AN, Alturki A, Alhawaidi FI, Alhadlq RK, Alramadhan M, Alobilan N, qroosh Ys

Prevalence and Risk Factors of Metabolic Dysfunction–Associated Steatotic Liver Disease in Patients With Type 2 Diabetes Mellitus at a Tertiary Center in Saudi Arabia: Cross-Sectional Questionnaire Study

JMIR Diabetes 2025;10:e77772

DOI: 10.2196/77772

PMID: 41183221

PMCID: 12582413

Prevalence and Risk Factors of MASLD in T2DM Patients at a Tertiary Center in Saudi Arabia

  • Abdulrahman Elnasieh; 
  • Mohammed Almesned; 
  • Akram N Al Hazmi; 
  • Atheer Alturki; 
  • Faisal I. Alhawaidi; 
  • Razan K. Alhadlq; 
  • Maryam Alramadhan; 
  • Nasser Alobilan; 
  • Yasser sheikh qroosh

ABSTRACT

Background:

The escalating rates of obesity and T2DM in Saudi Arabia highlight the impending burden of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) and nonalcoholic steatohepatitis

Objective:

The study aims to identify MASLD among T2DM patients at KSMC family medicine clinics, Riyadh, and explore associated factors to facilitate early intervention and prevention strategies.

Methods:

It is a cross-sectional study, which identified T2DM patients who attend KSMC Riyadh, and who had Ultrasound abdomen and diagnosed with MASLD. The study data was collected by a peer-reviewed validated data extraction sheet and analyzed by IBM SPSS 26.

Results:

Our study included 292 participants, with 47.3% (n=138) males and 52.7% (n=154) females. Prevalent comorbidities included dyslipidemia (n=218, 74.7%) and hypertension (n=209, 71.6%). Most were non-smokers (n=218, 74.7%). Notably, the prevalence of MASLD is 54.5% (n=159). Higher waist circumference associated significantly with MASLD (p=0.022), accounting for >80 cm among females (60.3%) and >94 cm males (54.5%) affected in different stages of MASLD. Obesity (BMI > 30) also significantly correlated with MASLD (p<0.001). Notably, individuals taking aspirin had half the odds of MASLD development (OR=0.523, p=0.007). Biochemical analysis revealed significant associations between MASLD and elevated ALT (p=0.009), AST (p=0.012), and HOMA-IR (p=0.001). Total cholesterol (p=0.010), triglycerides (p=0.029), and LDL (Low Density Lipoprotein) (p=0.036) were significantly elevated in MASLD patients. Insulin exhibited a significant positive correlation with MASLD (r=0.237, p=0.001). Glucose levels showed no significant association (r=0.029, p=0.628).

Conclusions:

Our study highlights the significant associations between Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and various factors including waist circumference, obesity, and certain biochemical markers. Furthermore, the protective effect of aspirin against MASLD warrants further investigation. These findings underscore the importance of early intervention and targeted preventive strategies.


 Citation

Please cite as:

Elnasieh A, Almesned M, Al Hazmi AN, Alturki A, Alhawaidi FI, Alhadlq RK, Alramadhan M, Alobilan N, qroosh Ys

Prevalence and Risk Factors of Metabolic Dysfunction–Associated Steatotic Liver Disease in Patients With Type 2 Diabetes Mellitus at a Tertiary Center in Saudi Arabia: Cross-Sectional Questionnaire Study

JMIR Diabetes 2025;10:e77772

DOI: 10.2196/77772

PMID: 41183221

PMCID: 12582413

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.